Nurtec® ODT (rimegepant) orally disintegrating tablets, 75mg 8-Unit Dose blister pack Recall
Issued March 16, 2023 · Biohaven Pharmaceuticals Inc. · 42 units affected
In March 2023, Biohaven Pharmaceuticals Inc. recalled the Nurtec® ODT (rimegepant) orally disintegrating tablets, 75mg 8-Unit Dose blister pack, a low-risk health recall reported by the CPSC.
Compiled by Maya Ellison, RecallCheckr
What this means for you
The recalled prescription drugs must be in child resistant packaging as required by the Poison Prevention Packaging Act (PPPA). The packaging of the products is not child resistant, posing a risk of poisoning if the contents are swallowed by young children.
What you should do
- 1 Stop using Nurtec® ODT (rimegepant) orally disintegrating tablets, 75mg 8-Unit Dose blister pack right away.
- 2 Set it aside where it won't be used by mistake.
- 3 Contact Biohaven Pharmaceuticals Inc. to arrange your new instructions. See the official notice below for contact details.
- 4 Keep the product until your remedy is fully processed. You may need it.
Recall details
- Brand
- Biohaven Pharmaceuticals Inc.
- Category
- Health
- Recall date
- March 16, 2023
- Units affected
- 42
- Sold at
- Pharmacies nationwide as a prescribed medicine from December 2021 through March 2023. The prices of the product varied based on health insurance terms and other factors.
- Recall number
- CPSC-23154
- Made in
- United States
- Issuing agency
- CPSC
In context
- Biohaven Pharmaceuticals Inc. has 1 recall in our database.
- We're tracking 3,576 Health recalls in our database.
- 42 units is enough to reach roughly 1 in every 3,119,048 US households.
- This is the 903rd Health recall we've logged in 2023.